133 related articles for article (PubMed ID: 12783694)
21. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
22. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
23. [The change of plasma von Willebrand factor and endothelin levels in patients with pregnancy induced hypertension].
Wang C; Jin L; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2001 Apr; 36(4):212-4. PubMed ID: 11783363
[TBL] [Abstract][Full Text] [Related]
24. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
[TBL] [Abstract][Full Text] [Related]
25. [Effects of chronic mercury poisoning on blood coagulation and fibrinolysis systems].
Song YG
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Dec; 23(6):405-7. PubMed ID: 16405768
[TBL] [Abstract][Full Text] [Related]
26. [The influence of I/D polymorphism of the angiotensin I converting enzyme (ACE) gene and 4G/5G polymorphism of plasminogen activator inhibitor (PAI-1) gene promoter on the haemostatic system in patients with essential hypertension and dyslipidemia].
Nowakowska A
Ann Acad Med Stetin; 2005; 51(1):95-105. PubMed ID: 16496609
[TBL] [Abstract][Full Text] [Related]
27. Changes in coagulation and tissue plasminogen activator after the treatment of cerebral infarction with lumbrokinase.
Jin L; Jin H; Zhang G; Xu G
Clin Hemorheol Microcirc; 2000; 23(2-4):213-8. PubMed ID: 11321442
[TBL] [Abstract][Full Text] [Related]
28. [Plasma haemostatic and fibrinolytic activities and their relationship to levels of serum lipids and apolipoproteins in endogenous hypertriglyceridemic patients].
Shen T; Bai H; Liu B; Liu Y; Zhang Z; Deng Z
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):405-8. PubMed ID: 12910674
[TBL] [Abstract][Full Text] [Related]
29. [Determination of plasma D-dimer in patients with pregnancy induced hypertension].
Zhou H; Chen R; Liu X
Zhonghua Fu Chan Ke Za Zhi; 1997 Jun; 32(6):347-9. PubMed ID: 9596914
[TBL] [Abstract][Full Text] [Related]
30. [Investigation on the causes of pregnancy induced hypertension].
Zhang Z; Cheng W; Duan T
Zhonghua Fu Chan Ke Za Zhi; 1996 Aug; 31(8):458-60. PubMed ID: 9275435
[TBL] [Abstract][Full Text] [Related]
31. Markers of endothelial activation in preeclampsia.
Prochazka M; Procházková J; Lubušký M; Pilka R; Úlehlová J; Michalec I; Polák P; Kacerovský M; Slavik L
Clin Lab; 2015; 61(1-2):39-46. PubMed ID: 25807636
[TBL] [Abstract][Full Text] [Related]
32. Coagulation inhibitors in preeclamptic pregnant women.
Osmanağaoğlu MA; Topçuoğlu K; Ozeren M; Bozkaya H
Arch Gynecol Obstet; 2005 Mar; 271(3):227-30. PubMed ID: 14735372
[TBL] [Abstract][Full Text] [Related]
33. [Changes of plasma fibronectin and antithrombin III in pregnancy-induced hypertension].
Tong Y
Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):6-8, 60. PubMed ID: 2004575
[TBL] [Abstract][Full Text] [Related]
34. Endothelial haemostatic markers in members of families with familial combined hyperlipidemia.
Karásek D; Vaverková H; Halenka M; Slavík L; Novotný D
Thromb Res; 2009; 123(3):466-75. PubMed ID: 18417194
[TBL] [Abstract][Full Text] [Related]
35. [Determination of platelet alpha-granule membrane protein in late pregnancy and oral contraceptive users].
Chen SL
Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):97-9, 124. PubMed ID: 7688274
[TBL] [Abstract][Full Text] [Related]
36. Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.
Bu C; Zhang C; Li Z; Gao L; Xie Z; Cai G
Clin Exp Immunol; 2007 Jul; 149(1):31-9. PubMed ID: 17425656
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of AT in pre-eclampsia: a case-control prospective trial.
Paternoster DM; Fantinato S; Manganelli F; Milani M; Nicolini U; Girolami A
Thromb Haemost; 2004 Feb; 91(2):283-9. PubMed ID: 14961155
[TBL] [Abstract][Full Text] [Related]
38. Fibrinolytic activity and protein C in preeclampsia.
Aznar J; Gilabert J; Estellés A; España F
Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
[TBL] [Abstract][Full Text] [Related]
39. Haemostatic factors in women with history of preeclampsia.
Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
[TBL] [Abstract][Full Text] [Related]
40. Investigation of thrombomodulin and plasminogen activator inhibitor type-I in pregnancy induced hypertension and its clinical significance.
Ma S; Bai C; Bian X
Chin Med Sci J; 2001 Sep; 16(3):169-71. PubMed ID: 12899332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
